EDWARDS LIFESCIENCES ($EW) posted quarterly earnings results for Q3 2026 on Wednesday, November 4th. The company reported earnings of $0.80 per share, beating estimates of $0.76 by $0.04. The company also reported revenue of $1,715,500,000, missing estimates of $1,726,379,693 by $-10,879,693.
Stock price change since market close: +2.26%
You can see Quiver Quantitative's $EW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EDWARDS LIFESCIENCES Insider Trading Activity
EDWARDS LIFESCIENCES insiders have traded $EW stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $EW stock by insiders over the last 6 months:
- DONALD E JR BOBO (CVP,Strategy/Corp Development) has made 0 purchases and 3 sales selling 41,113 shares for an estimated $3,472,871.
- DAVEEN CHOPRA (CVP, TMTT, Surgical & IHFM) has made 0 purchases and 3 sales selling 33,300 shares for an estimated $3,021,344.
- WAYNE MARKOWITZ (CVP, JAPAC) has made 0 purchases and 3 sales selling 11,014 shares for an estimated $944,962.
- DANIEL J. LIPPIS (CVP, TAVR) has made 0 purchases and 6 sales selling 3,715 shares for an estimated $327,798.
- BERNARD J ZOVIGHIAN (CEO) has made 0 purchases and 2 sales selling 3,443 shares for an estimated $291,116.
- ANNETTE BRULS (CVP, EMEACLA) sold 2,644 shares for an estimated $237,907
- ANDREW M. DAHL (SVP, Corporate Controller) has made 0 purchases and 2 sales selling 1,111 shares for an estimated $98,386.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EDWARDS LIFESCIENCES Hedge Fund Activity
We have seen 574 institutional investors add shares of EDWARDS LIFESCIENCES stock to their portfolio, and 627 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 22,783,175 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,060,966,010
- JENNISON ASSOCIATES LLC removed 12,827,871 shares (-98.2%) from their portfolio in Q2 2026, for an estimated $1,160,409,210
- ARISTOTLE CAPITAL MANAGEMENT, LLC added 8,665,712 shares (+inf%) to their portfolio in Q2 2026, for an estimated $783,900,307
- BLACKROCK, INC. added 6,198,500 shares (+11.8%) to their portfolio in Q2 2026, for an estimated $560,716,310
- FMR LLC removed 6,067,821 shares (-41.8%) from their portfolio in Q2 2026, for an estimated $548,895,087
- ALLIANCEBERNSTEIN L.P. added 5,193,061 shares (+149.8%) to their portfolio in Q2 2026, for an estimated $469,764,298
- WELLINGTON MANAGEMENT GROUP LLP removed 5,183,134 shares (-23.5%) from their portfolio in Q2 2026, for an estimated $468,866,301
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
EDWARDS LIFESCIENCES Analyst Ratings
Wall Street analysts have issued reports on $EW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/30/2026
To track analyst ratings and price targets for EDWARDS LIFESCIENCES, check out Quiver Quantitative's $EW forecast page.
EDWARDS LIFESCIENCES Price Targets
Multiple analysts have issued price targets for $EW recently. We have seen 5 analysts offer price targets for $EW in the last 6 months, with a median target of $104.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $110.0 on 07/08/2026
- Vijay Kumar from Evercore ISI Group set a target price of $100.0 on 07/06/2026
- Marie Thibault from BTIG set a target price of $110.0 on 06/30/2026
- Shagun Singh from RBC Capital set a target price of $100.0 on 06/16/2026
- Joshua Jennings from TD Cowen set a target price of $104.0 on 06/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
